Cargando…
Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical Perspectives
Multiple myeloma (MM) is a blood cell neoplasm characterized by excessive production of malignant monoclonal plasma cells (activated B lymphocytes) by the bone marrow, which end up synthesizing antibodies or antibody fragments, called M proteins, in excess. The accumulation of this production, both...
Autores principales: | Barreto, Igor Valentim, Machado, Caio Bezerra, Almeida, Davi Benevides, Pessoa, Flávia Melo Cunha de Pinho, Gadelha, Renan Brito, Pantoja, Laudreísa da Costa, Oliveira, Deivide de Sousa, Ribeiro, Rodrigo Monteiro, Lopes, Germison Silva, de Moraes Filho, Manoel Odorico, de Moraes, Maria Elisabete Amaral, Khayat, André Salim, de Oliveira, Edivaldo Herculano Correa, Moreira-Nunes, Caroline Aquino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506264/ https://www.ncbi.nlm.nih.gov/pubmed/36145532 http://dx.doi.org/10.3390/pharmaceutics14091784 |
Ejemplares similares
-
The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset
por: Gadelha, Renan Brito, et al.
Publicado: (2022) -
Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia
por: Pessoa, Flávia Melo Cunha de Pinho, et al.
Publicado: (2023) -
Leukemic Stem Cell: A Mini-Review on Clinical Perspectives
por: Barreto, Igor Valentim, et al.
Publicado: (2022) -
Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution
por: de Pinho Pessoa, Flávia Melo Cunha, et al.
Publicado: (2022) -
Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations
por: Machado, Caio Bezerra, et al.
Publicado: (2021)